Cargando…

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events

OBJECTIVE: The gut microbiota plays a key role in modulating host immune response. We conducted a prospective, observational study to examine gut microbiota composition in association with immune responses and adverse events in adults who have received the inactivated vaccine (CoronaVac; Sinovac) or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Siew C, Peng, Ye, Zhang, Lin, Mok, Chris KP, Zhao, Shilin, Li, Amy, Ching, Jessica YL, Liu, Yingzhi, Yan, Shuai, Chan, Dream L S, Zhu, Jie, Chen, Chunke, Fung, Adrian CH, Wong, Kenneth KY, Hui, David SC, Chan, Francis KL, Tun, Hein M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844967/ https://www.ncbi.nlm.nih.gov/pubmed/35140064 http://dx.doi.org/10.1136/gutjnl-2021-326563

Ejemplares similares

Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19
por: Zuo, Tao, et al.
Publicado: (2021)

Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
por: Hagin, David, et al.
Publicado: (2021)

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
por: van Leeuwen, Leanne P.M., et al.
Publicado: (2022)

Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects
por: Pham, Michele N., et al.
Publicado: (2022)

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
por: Syversen, Silje W., et al.
Publicado: (2022)

SG-APSIC1049: Immunogenicity of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines in seropositive and seronegative adults
por: Stoma, Igor, et al.
Publicado: (2023)

Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines
por: Peng, Ye, et al.
Publicado: (2023)

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
por: Mahil, Satveer K., et al.
Publicado: (2021)

Adverse Events Following COVISHIELD Vaccination Among Adult Population in Bangladesh
por: Khalil, Md. Musab, et al.
Publicado: (2021)

SG-APSIC1201: Knowledge and awareness of healthcare workers in a residential care home regarding the use of personal protective equipment (PPE) during the COVID-19 pandemic: A pilot study
por: Chung, Cho Yan, et al.
Publicado: (2023)

SG-APSIC1204: Time-based deisolation of generally asymptomatic immunocompetent COVID-19 patients on day 8 of infection to clean wards is safe
por: Fauzi, Nazira Binte Muhammad, et al.
Publicado: (2023)

Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities
por: Manjaly Thomas, Zita-Rose, et al.
Publicado: (2020)

Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
por: Noh, Yunha, et al.
Publicado: (2023)

Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea
por: Kwon, Yunhyung, et al.
Publicado: (2022)

Duration of exposure is the most important risk factor for nosocomial COVID-19 in open multibed wards
por: Chan, Hwang Ching, et al.
Publicado: (2022)

COVID-19 postvaccination adverse events and vaccine hesitancy among hospital employees: Is there a link?
por: Weiland, Anastasiia, et al.
Publicado: (2022)

Multifocal nivolumab immune-related adverse effects during asymptomatic SARS-CoV-2 infection: causality or casuality?
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Associations of racial and ethnic discrimination with adverse changes in exercise and screen time during the COVID-19 pandemic in the United States
por: Xia, Tong, et al.
Publicado: (2023)

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
por: Mariottini, Alice, et al.
Publicado: (2022)

Avoiding a crisis at Christmas: a systematic review of adverse health effects or ‘Chrishaps’ caused by traditional hazard sources and COVID‐19
por: Wild, Ursula, et al.
Publicado: (2022)

Post COVID‐19 vaccination: AusVaxSafety survey participation and adverse events – a community‐based regional Queensland study
por: Hamilton, Elizabeth, et al.
Publicado: (2022)

Repositioned Drugs for COVID-19—the Impact on Multiple Organs
por: Chan, Christina, et al.
Publicado: (2021)

Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
por: Consoli, Stefano, et al.
Publicado: (2021)

Containing COVID-19 in a specialised neurology centre: the risks of presymptomatic transmission
por: Wee, Liang En Ian, et al.
Publicado: (2020)

Pilot Study Using Telemedicine Video Consultation for Vascular Patients’ Care During the COVID-19 Period
por: Li, Hai-Lei, et al.
Publicado: (2020)

Anaesthetic Considerations for Rationalizing Drug Use in the Operating Theatre: Strategies in a Singapore Hospital During COVID-19
por: Au Yong, Phui Sze Angie, et al.
Publicado: (2020)

SG-APSIC1026: COVID-19 vaccine acceptance and hesitancy among primary healthcare workers in Singapore
por: Koh, Sky Wei Chee, et al.
Publicado: (2023)

COVID-19, Suffering and Palliative Care: A Review
por: Beng, Tan Seng, et al.
Publicado: (2021)

Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis
por: Tao, Jun, et al.
Publicado: (2021)

Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19
por: Chen, Shuai, et al.
Publicado: (2021)

Risk factors associated with SARS-CoV-2 transmission, outbreak duration, and mortality in Fraser Health acute-care settings
por: Duncombe, Tamara, et al.
Publicado: (2022)

Neurology podcast utilization during the COVID-19 pandemic
por: Siegler, James E., et al.
Publicado: (2021)

Angiotensin converting enzyme and sodium glucose cotransporter inhibitors alleviate inflammatory effects of SARS-CoV-2 in cardiomyocytes
por: Wong, Chun-Ka, et al.
Publicado: (2022)

Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19
por: Sims, Jonathan T., et al.
Publicado: (2021)

Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo
por: Yadav, Naveen, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on total, sex- and age-specific all-cause mortality in 20 countries worldwide during 2020: results from the C-MOR project
por: Demetriou, Christiana A, et al.
Publicado: (2022)

Reduced mortality during the COVID-19 outbreak in Japan, 2020: a two-stage interrupted time-series design
por: Onozuka, Daisuke, et al.
Publicado: (2021)

Nature in virtual reality improves mood and reduces stress: evidence from young adults and senior citizens
por: Chan, Sarah Hian May, et al.
Publicado: (2021)

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
por: Jin, Xi, et al.
Publicado: (2020)

A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?
por: Aksu, Saliha Buşra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_04ccu04jv3s704c63a9rhp0m0r